IBDEI0A0 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,4441,1,4,0)
 ;;=4^C4A.12
 ;;^UTILITY(U,$J,358.3,4441,2)
 ;;=^5001140
 ;;^UTILITY(U,$J,358.3,4442,0)
 ;;=C4A.11^^21^277^75
 ;;^UTILITY(U,$J,358.3,4442,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4442,1,3,0)
 ;;=3^Merkle Cell CA,Right Eyelid,Incl Canthus
 ;;^UTILITY(U,$J,358.3,4442,1,4,0)
 ;;=4^C4A.11
 ;;^UTILITY(U,$J,358.3,4442,2)
 ;;=^5001139
 ;;^UTILITY(U,$J,358.3,4443,0)
 ;;=C4A.72^^21^277^67
 ;;^UTILITY(U,$J,358.3,4443,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4443,1,3,0)
 ;;=3^Merkle Cell CA,Left Lower Limb,Incl Hip
 ;;^UTILITY(U,$J,358.3,4443,1,4,0)
 ;;=4^C4A.72
 ;;^UTILITY(U,$J,358.3,4443,2)
 ;;=^5001156
 ;;^UTILITY(U,$J,358.3,4444,0)
 ;;=C4A.62^^21^277^68
 ;;^UTILITY(U,$J,358.3,4444,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4444,1,3,0)
 ;;=3^Merkle Cell CA,Left Upper Limb,Incl Shoulder
 ;;^UTILITY(U,$J,358.3,4444,1,4,0)
 ;;=4^C4A.62
 ;;^UTILITY(U,$J,358.3,4444,2)
 ;;=^5001153
 ;;^UTILITY(U,$J,358.3,4445,0)
 ;;=C4A.71^^21^277^76
 ;;^UTILITY(U,$J,358.3,4445,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4445,1,3,0)
 ;;=3^Merkle Cell CA,Right Lower Limb,Incl Hip
 ;;^UTILITY(U,$J,358.3,4445,1,4,0)
 ;;=4^C4A.71
 ;;^UTILITY(U,$J,358.3,4445,2)
 ;;=^5001155
 ;;^UTILITY(U,$J,358.3,4446,0)
 ;;=C4A.61^^21^277^77
 ;;^UTILITY(U,$J,358.3,4446,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4446,1,3,0)
 ;;=3^Merkle Cell CA,Right Upper Limb,Incl Shoulder
 ;;^UTILITY(U,$J,358.3,4446,1,4,0)
 ;;=4^C4A.61
 ;;^UTILITY(U,$J,358.3,4446,2)
 ;;=^5001152
 ;;^UTILITY(U,$J,358.3,4447,0)
 ;;=C4A.31^^21^277^70
 ;;^UTILITY(U,$J,358.3,4447,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4447,1,3,0)
 ;;=3^Merkle Cell CA,Nose
 ;;^UTILITY(U,$J,358.3,4447,1,4,0)
 ;;=4^C4A.31
 ;;^UTILITY(U,$J,358.3,4447,2)
 ;;=^5001145
 ;;^UTILITY(U,$J,358.3,4448,0)
 ;;=C4A.39^^21^277^72
 ;;^UTILITY(U,$J,358.3,4448,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4448,1,3,0)
 ;;=3^Merkle Cell CA,Parts of Face,Other
 ;;^UTILITY(U,$J,358.3,4448,1,4,0)
 ;;=4^C4A.39
 ;;^UTILITY(U,$J,358.3,4448,2)
 ;;=^5001146
 ;;^UTILITY(U,$J,358.3,4449,0)
 ;;=C4A.59^^21^277^73
 ;;^UTILITY(U,$J,358.3,4449,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4449,1,3,0)
 ;;=3^Merkle Cell CA,Parts of Trunk,Other
 ;;^UTILITY(U,$J,358.3,4449,1,4,0)
 ;;=4^C4A.59
 ;;^UTILITY(U,$J,358.3,4449,2)
 ;;=^5001150
 ;;^UTILITY(U,$J,358.3,4450,0)
 ;;=C4A.8^^21^277^71
 ;;^UTILITY(U,$J,358.3,4450,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4450,1,3,0)
 ;;=3^Merkle Cell CA,Overlapping Sites
 ;;^UTILITY(U,$J,358.3,4450,1,4,0)
 ;;=4^C4A.8
 ;;^UTILITY(U,$J,358.3,4450,2)
 ;;=^5001157
 ;;^UTILITY(U,$J,358.3,4451,0)
 ;;=C4A.9^^21^277^78
 ;;^UTILITY(U,$J,358.3,4451,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4451,1,3,0)
 ;;=3^Merkle Cell CA,Unspec
 ;;^UTILITY(U,$J,358.3,4451,1,4,0)
 ;;=4^C4A.9
 ;;^UTILITY(U,$J,358.3,4451,2)
 ;;=^5001158
 ;;^UTILITY(U,$J,358.3,4452,0)
 ;;=I78.1^^21^278^8
 ;;^UTILITY(U,$J,358.3,4452,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4452,1,3,0)
 ;;=3^Nevus,Non-Neoplastic
 ;;^UTILITY(U,$J,358.3,4452,1,4,0)
 ;;=4^I78.1
 ;;^UTILITY(U,$J,358.3,4452,2)
 ;;=^269807
 ;;^UTILITY(U,$J,358.3,4453,0)
 ;;=L60.3^^21^278^2
 ;;^UTILITY(U,$J,358.3,4453,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4453,1,3,0)
 ;;=3^Nail Dystrophy
 ;;^UTILITY(U,$J,358.3,4453,1,4,0)
 ;;=4^L60.3
 ;;^UTILITY(U,$J,358.3,4453,2)
 ;;=^5009236
 ;;^UTILITY(U,$J,358.3,4454,0)
 ;;=L92.1^^21^278^4
 ;;^UTILITY(U,$J,358.3,4454,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4454,1,3,0)
 ;;=3^Necrobiosis Lipoidica NEC
 ;;^UTILITY(U,$J,358.3,4454,1,4,0)
 ;;=4^L92.1
 ;;^UTILITY(U,$J,358.3,4454,2)
 ;;=^5009462
